Downsides to the nitrate-nitrite-nitric oxide pathway in physiology and therapeutics?
- Published in:
- 2008
- By:
- Publication type:
- Letter
Works matching IS 14741776 AND DT 2008 AND VI 7 AND IP 8
Results: 24
1
2
Downsides to the nitrate–nitrite–nitric oxide pathway in physiology and therapeutics? Reply from Lundberg, Weitzberg and Gladwin.
- Published in:
- 2008
- By:
- Publication type:
- Letter
3
The nociceptin/orphanin FQ receptor: a target with broad therapeutic potential.
- Published in:
- 2008
- By:
- Publication type:
- research
4
The molecular epidemiology of pain: a new discipline for drug discovery.
- Published in:
- Nature Reviews Drug Discovery, 2008, v. 7, n. 8, p. 647, doi. 10.1038/nrd2595
- By:
- Publication type:
- Article
5
Pseudoreceptor models in drug design: bridging ligand- and receptor-based virtual screening.
- Published in:
- Nature Reviews Drug Discovery, 2008, v. 7, n. 8, p. 667, doi. 10.1038/nrd2615
- By:
- Publication type:
- Article
6
The adult human brain in preclinical drug development.
- Published in:
- Nature Reviews Drug Discovery, 2008, v. 7, n. 8, p. 659, doi. 10.1038/nrd2617
- By:
- Publication type:
- Article
7
Trends in disease focus of drug development.
- Published in:
- Nature Reviews Drug Discovery, 2008, v. 7, n. 8, p. 639, doi. 10.1038/nrd2618
- By:
- Publication type:
- Article
8
Targeting bile-acid signalling for metabolic diseases.
- Published in:
- Nature Reviews Drug Discovery, 2008, v. 7, n. 8, p. 678, doi. 10.1038/nrd2619
- By:
- Publication type:
- Article
9
In this issue.
- Published in:
- Nature Reviews Drug Discovery, 2008, v. 7, n. 8, p. 627, doi. 10.1038/nrd2639
- By:
- Publication type:
- Article
10
The future of pain.
- Published in:
- Nature Reviews Drug Discovery, 2008, v. 7, n. 8, p. 629, doi. 10.1038/nrd2640
- By:
- Publication type:
- Article
11
Analgesic R&D.
- Published in:
- Nature Reviews Drug Discovery, 2008, v. 7, n. 8, p. 711, doi. 10.1038/nrd2641
- Publication type:
- Article
12
Stroke: Widening the therapeutic window?
- Published in:
- Nature Reviews Drug Discovery, 2008, v. 7, n. 8, p. 643, doi. 10.1038/nrd2642
- By:
- Publication type:
- Article
13
Cancer: New target for tumour immunotherapy.
- Published in:
- Nature Reviews Drug Discovery, 2008, v. 7, n. 8, p. 644, doi. 10.1038/nrd2643
- By:
- Publication type:
- Article
14
Neurodegenerative diseases: Clearing up Aβ.
- Published in:
- Nature Reviews Drug Discovery, 2008, v. 7, n. 8, p. 644, doi. 10.1038/nrd2644
- By:
- Publication type:
- Article
15
Stem cells: Overcoming barriers to iPS cells.
- Published in:
- Nature Reviews Drug Discovery, 2008, v. 7, n. 8, p. 645, doi. 10.1038/nrd2645
- By:
- Publication type:
- Article
16
Proteases: Novel route to protease targeting.
- Published in:
- Nature Reviews Drug Discovery, 2008, v. 7, n. 8, p. 646, doi. 10.1038/nrd2646
- By:
- Publication type:
- Article
17
In Brief.
- Published in:
- Nature Reviews Drug Discovery, 2008, v. 7, n. 8, p. 646, doi. 10.1038/nrd2647
- Publication type:
- Article
18
Pharma pursues novel models for academic collaboration.
- Published in:
- Nature Reviews Drug Discovery, 2008, v. 7, n. 8, p. 631, doi. 10.1038/nrd2648
- By:
- Publication type:
- Article
19
Patent Watch.
- Published in:
- Nature Reviews Drug Discovery, 2008, v. 7, n. 8, p. 636, doi. 10.1038/nrd2651
- By:
- Publication type:
- Article
20
Carlo Incerti.
- Published in:
- 2008
- Publication type:
- Interview
21
Certolizumab pegol.
- Published in:
- Nature Reviews Drug Discovery, 2008, v. 7, n. 8, p. 641, doi. 10.1038/nrd2654
- By:
- Publication type:
- Article
22
Dealing with a data dilemma.
- Published in:
- Nature Reviews Drug Discovery, 2008, v. 7, n. 8, p. 632, doi. 10.1038/nrd2649
- Publication type:
- Article
23
News in brief.
- Published in:
- Nature Reviews Drug Discovery, 2008, v. 7, n. 8, p. 634, doi. 10.1038/nrd2650
- Publication type:
- Article
24
ASCO presentations highlight value of cancer biomarkers.
- Published in:
- 2008
- By:
- Publication type:
- Correction Notice